Group K Diagnostics and Health Network Laboratories Announce the Commencement of a Clinical Trial
News
Renovacor Closes $11 Million Series A Financing to Advance First Gene Therapy for a Rare Cardiovascular Disease
– Funding supports preclinical development through IND submission for its BAG3 gene therapy, the first gene replacement product for genetic forms of dilated cardiomyopathy
– Company announces leadership team and board of directors with leading scientists, physicians and experienced venture investors in cardiovascular and gene therapy fields
Relmada Therapeutics Announces Completion of Dosing with REL-1017 in Phase 2 Study of Individuals with Treatment Resistant Depression
REL-1017 is a novel NMDA receptor antagonist in development as a rapidly acting oral agent for the treatment of depression
HHS, DoD, VenatoRx Pharmaceuticals to Co-Develop Novel Antibiotic to Treat Drug-Resistant Infections
South Shore Health Selects Bainbridge Health to Enhance Medication Safety and Stewardship
Bainbridge Health is partnering with South Shore Health, a leading provider of emergency, acute and outpatient care, to enhance its efforts to improve safety and reduce medication waste.
Immunome Appoints Purnanand Sarma, PhD, as President and Chief Executive Officer
Industry Veteran to Take the Helm of Next-Generation Oncology Company Focused on Harnessing Human Immune Response
QR Pharma Adopts new Corporate Name: Annovis Bio
Change reflects enhanced focus on neurodegenerative diseases
Nemours Children’s Health System Expands Partnership with Bainbridge Health to Support Its Continued Commitment to Medication Safety
Bainbridge Health is partnering with Nemours Children’s Hospital to further support the system’s efforts to improve medication and infusion pump safety.
VenatoRx Pharmaceuticals Founders Named Entrepreneur Of The Year 2019 Award Winners in Greater Philadelphia